High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4

GLIA

Volumn 62, Issue 1, 2014, Pages 26-38

  Laird, Melissa D ^a   Shields, Jessica S ^a   Sukumari Ramesh, Sangeetha ^a   Kimbler, Donald E ^a   Fessler, R David ^a   Shakir, Basheer ^a   Youssef, Patrick ^a   Yanasak, Nathan ^a   Vender, John R ^a   Dhandapani, Krishnan M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Controlled cortical impact; DAMP; Innate immunity; Intracranial pressure; Neuroinflammation

Indexed keywords

4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; AQUAPORIN 4; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOMODULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NVPAAM 077; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VGX 1027;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN EDEMA; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MEDIATOR; MICROGLIA; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RODENT; SIGNAL TRANSDUCTION; TISSUE CULTURE; TRAUMATIC BRAIN INJURY;

CONTROLLED CORTICAL IMPACT; DAMP; INNATE IMMUNITY; INTRACRANIAL PRESSURE; NEUROINFLAMMATION;

ACETATES; ANIMALS; BRAIN EDEMA; BRAIN INJURIES; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICE; MICE, INBRED C3H; MICROGLIA; NEURONS; OXAZOLES; RIBOSOMAL PROTEINS; TOLL-LIKE RECEPTOR 4;

EID: 84888135752     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22581     Document Type: Article

References (59)

1. Alberico AM, Ward JD, Choi SC, Marmarou A, Young HF. 1987. Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adult patients. J Neurosurg 67:648-656.
2. Anastasio NC, Xia Y, O'Connor ZR, Johnson KM. 2009. Differential role of N-methyl-d-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits. Neuroscience 163:1181-1191.
3. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. 1995. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973.
4. Badaut J, Lasbennes F, Magistretti PJ, Regli L. 2002. Aquaporins in brain: Distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 22:367-378.
5. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E. 2004. Dynamic changes in N-methyl-d-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA 101:5117-5122.
6. Bohmer AE, Oses JP, Schmidt AP, Peron CS, Krebs CL, Oppitz PP, D'Avila TT, Souza DO, Portela LV, Stefani MA. 2011. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68:1624-1630; discussion 1630-1631.
7. Chaperon F, Muller W, Auberson YP, Tricklebank MD, Neijt HC. 2003. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-d-aspartate receptor antagonists: Preferential involvement of the NR2B rather than NR2A subunit. Behav Pharmacol 14:477-487.
8. Cull-Candy SG, Leszkiewicz DN. 2004. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004:re16.
9. Czigner A, Mihaly A, Farkas O, Buki A, Krisztin-Peva B, Dobo E, Barzo P. 2007. Kinetics of the cellular immune response following closed head injury. Acta Neurochir (Wien) 149:281-289.
10. Dempsey RJ, Baskaya MK, Dogan A. 2000. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-d-aspartate receptor antagonist, after experimental traumatic brain injury in rats. Neurosurgery 47:399-404; discussion 404-406.
11. Faden AI, Demediuk P, Panter SS, Vink R. 1989. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800.
12. Fox CJ, Russell KI, Wang YT, Christie BR. 2006. Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo. Hippocampus 16:907-915.
13. Gao HM, Zhou H, Zhang F, Wilson BC, Kam W, Hong JS. 2011. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci 31:1081-1092.
14. Gunnarson E, Zelenina M, Axehult G, Song Y, Bondar A, Krieger P, Brismar H, Zelenin S, Aperia A. 2008. Identification of a molecular target for glutamate regulation of astrocyte water permeability. Glia 56:587-596.
15. Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, Hosotubo H, Kieko F, Yamashita T, Tanaka H, Shimazu T, Sugimoto H. 2004. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22:102-107.
16. Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH III, Clifton GL, Dash PK. 2010. Serum IL-6: A candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 7:19.
17. Ikonomidou C, Turski L. 2002. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1:383-386.
18. Ito J, Marmarou A, Barzo P, Fatouros P, Corwin F. 1996. Characterization of edema by diffusion-weighted imaging in experimental traumatic brain injury. J Neurosurg 84:97-103.
19. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA, Leemans JC, Sutterwala FS. 2009. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 106:20388-20393.
20. Katayama Y, Kawamata T. 2003. Edema fluid accumulation within necrotic brain tissue as a cause of the mass effect of cerebral contusion in head trauma patients. Acta Neurochir Suppl 86:323-327.
21. Kawamata T, Katayama Y. 2006. Surgical management of early massive edema caused by cerebral contusion in head trauma patients. Acta Neurochir Suppl 96:3-6.
22. Kawamata T, Katayama Y. 2007. Cerebral contusion: A role model for lesion progression. Prog Brain Res 161:235-241.
23. Kimbler DE, Shields J, Yanasak N, Vender JR, Dhandapani KM. 2012. Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS One 7:e41229.
24. Kimelberg HK. 1992. Astrocytic edema in CNS trauma. J Neurotrauma 9 (Suppl 1):S71-S81.
25. King MD, McCracken DJ, Wade FM, Meiler SE, Alleyne CH Jr, Dhandapani KM. 2011. Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice. J Neurosurg 115:116-123.
26. Klatzo I. 1967. Presidental address. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol 26:1-14.
27. Lai AY, Todd KG. 2008. Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 56:259-270.
28. Laird MD, Sukumari-Ramesh S, Swift AE, Meiler SE, Vender JR, Dhandapani KM. 2010. Curcumin attenuates cerebral edema following traumatic brain injury in mice: A possible role for aquaporin-4? J Neurochem 113:637-648.
29. Levin HS, Eisenberg HM, Gary HE, Marmarou A, Foulkes MA, Jane JA, Marshall LF, Portman SM. 1991. Intracranial hypertension in relation to memory functioning during the first year after severe head injury. Neurosurgery 28:196-199; discussion 200.
30. Malherbe P, Mutel V, Broger C, Perin-Dureau F, Kemp JA, Neyton J, Paoletti P, Kew JN. 2003. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket. J Pharmacol Exp Ther 307:897-905.
31. Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman AS. 2000. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6:159-163.
32. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045.
33. Miller JD, Becker DP, Ward JD, Sullivan HG, Adams WE, Rosner MJ. 1977. Significance of intracranial hypertension in severe head injury. J Neurosurg 47:503-516.
34. Milnerwood AJ, Kaufman AM, Sepers MD, Gladding CM, Zhang L, Wang L, Fan J, Coquinco A, Qiao JY, Lee H, Wang YT, Cynader M, Raymond LA. 2012. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice. Neurobiol Dis 48:40-51.
35. Mollica L, De Marchis F, Spitaleri A, Dallacosta C, Pennacchini D, Zamai M, Agresti A, Trisciuoglio L, Musco G, Bianchi ME. 2007. Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. Chem Biol 14:431-441.
36. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, Bullock MR, Choi SC, Clifton GL, Contant CF, Coplin WM, Dietrich WD, Ghajar J, Grady SM, Grossman RG, Hall ED, Heetderks W, Hovda DA, Jallo J, Katz RL, Knoller N, Kochanek PM, Maas AI, Majde J, Marion DW, Marmarou A, Marshall LF, McIntosh TK, Miller E, Mohberg N, Muizelaar JP, Pitts LH, Quinn P, Riesenfeld G, Robertson CS, Strauss KI, Teasdale G, Temkin N, Tuma R, Wade C, Walker MD, Weinrich M, Whyte J, Wilberger J, Young AB, Yurkewicz L. 2002. Clinical trials in head injury. J Neurotrauma 19:503-557.
37. Nase G, Helm PJ, Enger R, Ottersen OP. 2008. Water entry into astrocytes during brain edema formation. Glia 56:895-902.
38. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318.
39. Nortje J, Menon DK. 2004. Traumatic brain injury: physiology, mechanisms, and outcome. Curr Opin Neurol 17:711-718.
40. Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, Kullak-Ublick GA, Gerken G, Zeuzem S, Nevens F, Tielemans WC, Zondervan PE, Lagging M, Westin J, Schalm SW. 2006. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial. J Hepatol 45:539-546.
41. Palmer AM, Marion DW, Botscheller ML, Swedlow PE, Styren SD, DeKosky ST. 1993. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 61:2015-2024.
42. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. 2004. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18:1291-1293.
43. Parker LC, Prince LR, Sabroe I. 2007. Translational mini-review series on Toll-like receptors: Networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol 147:199-207.
44. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. 2001. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 18:491-498.
45. Sahuquillo J, Arikan F. 2006. Decompressive craniectomy for the treatment of refractory high intracranial pressure in traumatic brain injury. Cochrane Database Syst Rev CD003983.
46. Saul TG, Ducker TB. 1982. Effect of intracranial pressure monitoring and aggressive treatment on mortality in severe head injury. J Neurosurg 56:498-503.
47. Schafer DP, Lehrman EK, Stevens B. 2013. The "quad-partite" synapse: Microglia-synapse interactions in the developing and mature CNS. Glia 61:24-36.
48. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY. 1994. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368:144-147.
49. Stojanovic I, Cuzzocrea S, Mangano K, Mazzon E, Miljkovic D, Wang M, Donia M, Al Abed Y, Kim J, Nicoletti F, Stosic-Grujicic S, Claesson M. 2007. In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models. Clin Immunol 123:311-323.
50. Stosic-Grujicic S, Cvetkovic I, Mangano K, Fresta M, Maksimovic-Ivanic D, Harhaji L, Popadic D, Momcilovic M, Miljkovic D, Kim J, Al-Abed Y, Nicoletti F. 2007. A potent immunomodulatory compound, (S, R)-3-phenyl-4, 5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice. J Pharmacol Exp Ther 320:1038-1049.
51. Sukumari-Ramesh S, Alleyne CH Jr, Dhandapani KM. 2012. Astrocyte-specific expression of survivin after intracerebral hemorrhage in mice: A possible role in reactive gliosis? J Neurotrauma 29:2798-2804.
52. Sukumari-Ramesh S, Laird MD, Singh N, Vender JR, Alleyne CH Jr, Dhandapani KM. 2010. Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells. Glia 58:1858-1870.
53. Unterberg AW, Stover J, Kress B, Kiening KL. 2004. Edema and brain trauma. Neuroscience 129:1021-1029.
54. Wakade C, King MD, Laird MD, Alleyne CH Jr, Dhandapani KM. 2009. Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. Antioxid Redox Signal 11:35-45.
55. Won J, Kim M, Kim N, Ahn JH, Lee WG, Kim SS, Chang KY, Yi YW, Kim TK. 2006. Small molecule-based reversible reprogramming of cellular lifespan. Nat Chem Biol 2:369-374.
56. Yang B, Zador Z, Verkman AS. 2008. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem 283:15280-15286.
57. Yang K, Trepanier C, Sidhu B, Xie YF, Li H, Lei G, Salter MW, Orser BA, Nakazawa T, Yamamoto T, Jackson MF, Macdonald JF. 2012. Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases. EMBO J 31:805-816.
58. Youn HS, Saitoh SI, Miyake K, Hwang DH. 2006. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol 72:62-69.
59. Zhou F, Chen G, Zhang J. 2009. Edaravone reduces brain oedema and attenuates cell death after intracerebral haemorrhage in mice. Brain Inj 23:353-357.